Quick Answer
ACADIA PHARMACEUTICALS INC reported Total Assets of $1.56 billion for fiscal year 2025.
ACADIA PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.56B | +31.7% |
| 2024 | $1.19B | +58.6% |
| 2023 | $748.96M | +27.4% |
| 2022 | $587.81M | -16.0% |
| 2021 | $700.12M | -10.5% |
| 2020 | $782.62M | -0.1% |
| 2019 | $783.18M | +45.0% |
| 2018 | $540.20M | +40.5% |
| 2017 | $384.51M | -31.5% |
| 2016 | $561.15M | +152.9% |
| 2015 | $221.90M | -31.8% |
| 2014 | $325.46M | +72.1% |
| 2013 | $189.12M | +74.2% |
| 2012 | $108.59M | +238.1% |
| 2011 | $32.11M | -16.4% |
| 2010 | $38.39M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.33B | +36.2% | +8.6% |
| June 30, 2025 | $1.23B | +34.1% | +8.2% |
| March 31, 2025 | $1.13B | +32.4% | -4.7% |
| December 31, 2024 | $1.19B | +58.6% | +21.6% |
| September 30, 2024 | $976.87M | +54.4% | +6.9% |
| June 30, 2024 | $914.10M | +42.2% | +6.9% |
| March 31, 2024 | $855.10M | +30.5% | +14.2% |
| December 31, 2023 | $748.96M | +27.4% | +18.4% |
- ACADIA PHARMACEUTICALS INC showed an increase of +31.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, ACADIA PHARMACEUTICALS INC’s total assets has grown by 3974.1% (from $38.39 million to $1.56 billion).
- The most recent figure is from ACADIA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: